Firefly Bio Acquired by Johnson & Johnson

Foley Hoag advised Vesica Health in its sale to Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics. The Foley Hoag team advising Vesica Health included Jeffrey Quillen, Shane Safer, Sarah Kelley, and Nathan Wright.

Foley Hoag advised Vesica Health in its sale to Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics. The Foley Hoag team advising Vesica Health included Jeffrey Quillen, Shane Safer, Sarah Kelley, and Nathan Wright.

The Colors of SM initiative is an incredible program that pairs rare disease patients with artists to translate invisible, complex medical realities into tangible visual art. I was incredibly honored to be able to attend this program a couple of years ago. 💛 Living with Systemic Mastocytosis means managing a heavy clinical burden, but it also means navigating an illness that people cannot see. Programs like this bridge the massive gap between data points on a lab report and the actual, human, lived experience. It reminds us that medicine isn't just about managing mast cells; it's about treating the whole person. #SystemicMastocytosis #RareDisease #PatientAdvocacy #TwistOutCancer #ColorsofSM #Healthcare #CreativeTherapy

We are truly honoured to be part of this milestone moment for Pancreatic Cancer Europe. At Sycai Medical, our mission has always been rooted in the belief that earlier detection saves lives — and nowhere is that more urgent than in pancreatic cancer. Partnering with PCE in this 10th anniversary year feels not only meaningful, but necessary. Over the past decade, PCE has built something remarkable: a united voice for patients, clinicians, researchers, and policymakers across Europe. We deeply admire that work, and we are excited to contribute to it. We look forward to a year of shared purpose — raising awareness, advancing earlier diagnosis, and working together toward the day when a pancreatic cancer diagnosis is no longer a devastating one. Thank you for welcoming Sycai Medical into the PCE family. The best is yet to come. #PancreaticCancer #PCE10years #AI #DigitalHealth #medtech

🤝 Sycai Medical is genuinely proud to stand alongside Pancreatic Cancer Europe as it marks its 10th anniversary, joining forces around a shared ambition to improve outcomes for patients across Europe. At the heart of what we do is a belief that smarter, AI-powered imaging can make a real difference — helping clinicians detect pancreatic cancer earlier and make more informed decisions when it matters most. By collaborating with PCE, we want to play our part in raising awareness, supporting healthcare professionals, and contributing to more effective, patient-centred care pathways.

Inspired by the work across AstraZeneca to deepen our understanding of blood cancer. At #EHA2026, our team is bringing together science, expertise and shared commitment to explore the complexity of the disease and what more could be possible for patients over time. Watch the film to see what drives us. 🔬

Inspired by the work across AstraZeneca to deepen our understanding of blood cancer. At #EHA2026, our team is bringing together science, expertise and shared commitment to explore the complexity of the disease and what more could be possible for patients over time. Watch the film to see what drives us. 🔬

Inspired by the work across AstraZeneca to deepen our understanding of blood cancer. At #EHA2026, our team is bringing together science, expertise and shared commitment to explore the complexity of the disease and what more could be possible for patients over time. Watch the film to see what drives us. 🔬

Inspired by the work across AstraZeneca to deepen our understanding of blood cancer. At #EHA2026, our team is bringing together science, expertise and shared commitment to explore the complexity of the disease and what more could be possible for patients over time. Watch the film to see what drives us. 🔬

Inspired by the work across AstraZeneca to deepen our understanding of blood cancer. At #EHA2026, our team is bringing together science, expertise and shared commitment to explore the complexity of the disease and what more could be possible for patients over time. Watch the film to see what drives us. 🔬